Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
60.36 USD | -2.11% | -5.35% | +9.47% |
21/05 | Ani Pharmaceuticals Insider Sold Shares Worth $794,568, According to a Recent SEC Filing | MT |
20/05 | ANI Pharmaceuticals Launches Kionex Suspension | MT |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+9.47% | 1.17B | |
+38.69% | 728B | |
+33.61% | 603B | |
-4.49% | 360B | |
+20.24% | 332B | |
+2.12% | 279B | |
+15.99% | 244B | |
+7.62% | 207B | |
-5.52% | 205B | |
-0.35% | 163B |
- Stock Market
- Equities
- ANIP Stock
- News ANI Pharmaceuticals, Inc.
- (ANIP) ANI PHARMACEUTICALS Forecasts Fiscal Year 2024 Revenue Range $520M - $542M